Paloma Partners Management CO Abbott Laboratories Call Options Transaction History

Paloma Partners Management CO

$3.08 Billion
Q3 2024

Call Options

20 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$100.07 - $118.13 $4.95 Million - $5.85 Million	49,500 Added 351.06%	63,600 $7.25 Million
Q2 2024 Aug 14, 2024	BUY	$100.73 - $112.44 $573,959 - $640,683	5,698 Added 67.82%	14,100 $1.47 Million
Q1 2024 May 15, 2024	BUY	$109.52 - $120.96 $920,187 - $1.02 Million	8,402 New	8,402 $954,000
Q3 2023 Nov 14, 2023	BUY	$95.53 - $114.62 $1.03 Million - $1.24 Million	10,800 Added 20.77%	62,800 $6.08 Million
Q2 2023 Aug 14, 2023	SELL	$100.78 - $112.29 $1.76 Million - $1.97 Million	-17,500 Reduced 25.18%	52,000 $5.67 Million
Q1 2023 May 15, 2023	BUY	$96.86 - $114.01 $6.73 Million - $7.92 Million	69,500 New	69,500 $7.04 Million
Q3 2022 Nov 14, 2022	SELL	$96.76 - $112.03 $919,220 - $1.06 Million	-9,500 Reduced 19.87%	38,300 $3.71 Million
Q2 2022 Aug 15, 2022	SELL	$102.07 - $123.37 $102,070 - $123,370	-1,000 Reduced 2.05%	47,800 $5.19 Million
Q1 2022 May 16, 2022	BUY	$114.02 - $139.04 $3.82 Million - $4.66 Million	33,500 Added 218.95%	48,800 $5.78 Million
Q1 2021 May 17, 2021	SELL	$108.84 - $128.23 $740,112 - $871,963	-6,800 Reduced 30.77%	15,300 $1.83 Million
Q4 2020 Feb 16, 2021	BUY	$105.0 - $114.42 $1.09 Million - $1.19 Million	10,400 Added 88.89%	22,100 $2.42 Million
Q2 2020 Aug 14, 2020	SELL	$76.57 - $98.0 $1.49 Million - $1.91 Million	-19,500 Reduced 62.5%	11,700 $1.07 Million
Q4 2019 Feb 14, 2020	BUY	$78.51 - $87.4 $298,338 - $332,120	3,800 Added 13.87%	31,200 $2.71 Million
Q3 2019 Nov 14, 2019	SELL	$81.84 - $88.74 $3.49 Million - $3.78 Million	-42,600 Reduced 60.86%	27,400 $2.29 Million
Q1 2019 May 15, 2019	BUY	$66.22 - $80.06 $4.64 Million - $5.6 Million	70,000 New	70,000 $5.6 Million
Q4 2018 Feb 14, 2019	SELL	$65.56 - $74.27 $2.73 Million - $3.09 Million	-41,600 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$60.81 - $73.36 $674,991 - $814,296	-11,100 Reduced 21.06%	41,600 $3.05 Million
Q1 2018 May 15, 2018	BUY	$56.27 - $63.62 $883,439 - $998,834	15,700 Added 42.43%	52,700 $3.16 Million
Q4 2017 Feb 14, 2018	SELL	$53.68 - $57.47 $2.54 Million - $2.72 Million	-47,400 Reduced 56.16%	37,000 $2.11 Million
Q3 2017 Nov 14, 2017	BUY	$48.06 - $53.64 $4.06 Million - $4.53 Million	84,400	84,400 $4.5 Million

Others Institutions Holding ABT

# of Institutions

3,185

Shares Held

1.31B

Call Options Held

8.74M

Put Options Held

7.89M

Vanguard Group Inc Valley Forge, PA

168M
Shares

$19.3 Billion
0.35% of portfolio
Black Rock Inc. New York, NY

131M
Shares

$15.1 Billion
0.31% of portfolio
State Street Corp Boston, MA

76.7M
Shares

$8.83 Billion
0.36% of portfolio
Capital International Investors Los Angeles, CA

65.7M
Shares

$7.56 Billion
1.49% of portfolio
Capital Research Global Investors Los Angeles, CA

53.3M
Shares

$6.13 Billion
1.31% of portfolio

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $201B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Paloma Partners Management CO with notifications on news.

Account